TWITTER

• Are you in #Suzhou this week? Looking for the next best-in-class targeted cancer therapeutic for your development… https://t.co/EbCVLRTLIm 2 days ago
• Why are our ADCs so potent at killing cancer cells and so well tolerated? Come and see the latest data during next… https://t.co/uZKctJ81zF 2 weeks ago
• At #AACR next week you can hear the latest compelling efficacy and safety data from preclinical studies conducted w… https://t.co/ZXWxSaRNEd 2 weeks ago
• Grateful for the growing interest in in what we are working on at Synaffix with standing standing room only at this… https://t.co/XngOJNyfbw 1 month ago